Abstract

Research and evidence are critical for informing policies and practices in support of population healthcare and equity. In the past 2 decades, ChinaCLEN's roles and responsibilities promote evidence-based policy-making in China. Evidence-based policy has become a major part of governments' approaches for policy making and the machinery of government. In this presentation I will mainly focus on the transformation of national government healthy policy and strategies according to the expansion of evidence-based medicine in China, as well as the opportunities and challenges in the future. During the symposium following aspects in China will be discussed: 1. Organisation on the Evidence Based Health Care; 2. Impacts on Government Healthy Policy Decision-Making; 3. The prioritised research agenda special focus on clinical research identified and advocated for key research needs in 2011–2015; 4. Contributions on evidence based public health safety policy and practice; 5. Standards for scientific review of the clinical efficacy of Chinese traditional medicine; 6. Establishing integration system of traditional Chinese medicine and clinical research; 7. Improving accessibility and availability of sound evidence; and, 8. Future Opportunities and Challenges.